Vancouver biotech firm Absci inks 10 deals for drug discovery programs worth $1 billion

Vancouver biotechnology company Absci has secured nearly $1 billion in contracts in recent weeks, bolstering the business that’s struggled against economic headwinds.
Read more…
Source: The Columbian